Home Glaxo gets OK to expand marketing of inhaler drug
 

Keywords :   


Glaxo gets OK to expand marketing of inhaler drug

2015-05-01 00:31:09| Biotech - Topix.net

GlaxoSmithKline plc says it has received U.S. approval to sell its once-a-day respiratory inhaler Breo Ellipta for a new use in asthma patients ages 18 and older. The expanded approval from the Food and Drug Administration will help Glaxo replace sales of its best-selling product, Advair, which faces generic competition in Europe and pricing pressures in the U.S. Breo Ellipta was originally approved to treat a form of lung disease.

Tags: marketing expand drug glaxo

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11
26.11AKG WMS40 PRO MINI DUAL INST
26.1139THIRTY
26.1118
26.11 v-10
26.11 19 4000MHG
26.11KING GOLF. VOLUME 131.34.36.38.39
26.11
More »